Expiration Date: 12/06/2023
*Please note that you must complete the Post Webinar Evaluation (link below) to receive CE credit.
Natasha Tobarran, DO
University of Maryland School of Medicine
Emily Kershner, MD
Virginia Commonwealth University Health System
Virginia Poison Center
Nick Brandehoff, MD
Assistant Professor, Department of Emergency Medicine
University of Colorado – Denver
Shawn M. Varney, MD, FAACT, FACEP, FACMT
Professor of Emergency Medicine
Medical Director, South Texas Poison Center
University of Texas Health Science Center San Antonio
Has disclosed no relevant financial relationships
Almost 5,000 snakebites occur each year in the United States due to North American pit vipers, particularly copperheads, cottonmouths, and rattlesnakes. Treatment has progressed and outcomes have improved over the last two decades with the Fab fragment antivenom formulations compared to the prior whole-IgG products. Envenomation from exotic snakes is far less common but poses a difficult problem since species-specific antivenom is generally not readily available. The Gaboon viper (Bitis gabonica) is an African viper that possesses a tissue toxin and hemotoxin. Treatment is less clear when specific antivenom is unavailable. This webinar will provide the opportunity for toxicologists to be presented with up-to-date literature and treatment options for the Gaboon viper.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire webinar as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Physicians and Pharmacists
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Academy of Clinical Toxicology. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM for physicians and 1 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of the activity to meet the deadline for submission to CPE Monitor.
Objectives – After attending this program you should be able to:
- Describe the excepted clinical course after a Gaboon viper envenomation
- Discuss the role of expired antivenom and North American Crotalid Antivenom in Gaboon viper envenomations
- Review the risk of delayed coagulopathy and serum sickness after antivenom treatment
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.